Medtronic expands Swiss-based European HQ
Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.The project
Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.
The project brings Medtronics total investment in its Swiss facilities to $67 million. The expansion will add 200 new jobs, double Medtronics production capacity, provide a training center, and add room for administrative personnel, said Barry Wilson, Medtronics president of Europe, Africa, and the Middle East.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
